Chennai Meenakshi Multispeciality Hospital Ltd vs Medinova Diagnostic Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Chennai Meenakshi Multispeciality Hospital Ltd is ₹ 36.4 as of 23 Oct 15:30 . The P/E Ratio of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Medinova Diagnostic Services Ltd(Merged) changed from 11.3 on March 2021 to 20 on March 2025 . This represents a CAGR of 12.10% over 5 years The Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Medinova Diagnostic Services Ltd(Merged) changed from ₹ 22.86 crore on March 2021 to ₹ 37.95 crore on March 2025 . This represents a CAGR of 10.67% over 5 years The revenue of Chennai Meenakshi Multispeciality Hospital Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Medinova Diagnostic Services Ltd(Merged) for the Sep '25 is ₹ 2.53 crore as compare to the Jun '25 revenue of ₹ 2.78 crore. This represent the decline of -8.99% The ebitda of Chennai Meenakshi Multispeciality Hospital Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Medinova Diagnostic Services Ltd(Merged) for the Sep '25 is ₹ 0.95 crore as compare to the Jun '25 ebitda of ₹ 1.11 crore. This represent the decline of -14.41% The net profit of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of 0.0% The net profit of Medinova Diagnostic Services Ltd(Merged) changed from ₹ 0.42 crore to ₹ 0.51 crore over 6 quarters. This represents a CAGR of 13.82% The Dividend Payout of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Medinova Diagnostic Services Ltd(Merged) changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Chennai Meenakshi Multispeciality Hospital Ltd

Chennai Meenakshi Multispeciality Hospital Limited, formerly known as Devaki Hospital Limited, was incorporated in 1990.
The Company name was changed from Devaki Hospital Limited to Chennai Meenakshi Multispeciality Hospital Limited in October, 2007.
It is a 100-bedded hospital located in the heart of Chennai at Mylapore.
The hospital has an infrastructure comprising of around 105 Beds including ICU Beds, Operating Theatre, a modern dialysis Unit besides a host of other facilities.
The Company has a pool of talented and experienced doctors who are further supported by a team of highly qualified and experienced and dedicated support staff and cutting edge technology. The Company operate into various departments like Cardiology Department; Casualty Department; Diagnostic Services; Intensive Care Unit; Nephrology Department and Physiotherapy Department.

About Medinova Diagnostic Services Ltd

Medinova Diagnostic Services Limited (MDSL), incorporated in 1985, commenced business on 26 March, 1993.
It belongs to Standard Organics Group.
The Company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations, radiology & imaging, conventional, specialized lab services and diagnostic cardiology. MDSL has acquired the business and undertaking of the diagnostic services division of Standard Medical & Pharmaceuticals (SMPL) as a going concern together with assets and liabilities from 1 Apr.'93.
It has four main diagnostic centres in Hyderabad, Bangalore, Pune, and Kolkata apart from mini/medium-sized franchise centres at Karimnagar, Mancherial, Vizag, Nellore. MDSL came out with a public issue of 67.50 lac equity shares at par, aggregating Rs 6.

FAQs for the comparison of Chennai Meenakshi Multispeciality Hospital Ltd and null

Which company has a larger market capitalization, Chennai Meenakshi Multispeciality Hospital Ltd or Medinova Diagnostic Services Ltd?

Market cap of Chennai Meenakshi Multispeciality Hospital Ltd is 27 Cr while Market cap of Medinova Diagnostic Services Ltd is 43 Cr

What are the key factors driving the stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Medinova Diagnostic Services Ltd?

The stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Medinova Diagnostic Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chennai Meenakshi Multispeciality Hospital Ltd and Medinova Diagnostic Services Ltd?

As of October 25, 2026, the Chennai Meenakshi Multispeciality Hospital Ltd stock price is INR ₹36.4. On the other hand, Medinova Diagnostic Services Ltd stock price is INR ₹43.45.

How do dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Medinova Diagnostic Services Ltd compare?

To compare the dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Medinova Diagnostic Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.